Schonfeld Strategic Advisors LLC Eye Point Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$7.99 - $15.36 $303,220 - $582,912	37,950 New	37,950 $303,000
Q4 2022 Feb 14, 2023	BUY	$2.37 - $7.2 $24,648 - $74,880	10,400 New	10,400 $36,000
Q1 2021 May 17, 2021	SELL	$8.89 - $14.92 $95,123 - $159,644	-10,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.7 - $6.58 $39,590 - $70,406	10,700 New	10,700 $71,000

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.